Investor Presentaiton

Key Financials Q2 FY16 Q2 FY16 (All Figures in Rs. Mn) Q2 FY15 CHANGE -15% SUN PHARMA Net Sales Gross Profit Gross Margin EBITDA 68,033 79,793 52,450 61,621 -15% 77% 77% 18,994 30,061 -37% EBITDA Margin 28% 38% Net Profit 11,067 20,502 -46% Net margin 16% 26% R&D 4,981 4,363 14% R&D as % of Net Sales 7.3% 5.5% EPS (Diluted) INR 4.6 8.5 -46% © Sun Pharmaceutical Industries Limited. All Rights Reserved. 50

View entire presentation